Anuh Pharma Share Price | Anuh Pharma Stock Screener
ANUHPHR
Pharmaceuticals
Share Price NSE
₹79.45
▼
-1.21 (-1.50%)
Share Price BSE
₹79.16
▼
-1.63 (-2.02%)
As of July 23, 2026, the Anuh Pharma share price (NSE: ANUHPHR) is ₹79.45 on NSE and ₹79.16 on BSE, down 1.50% from the previous close, with shares trading between ₹79.00 and ₹81.49, and a 52-week range of ₹67.00–₹99.41.
Analyse ANUHPHR stock price history and track historical price performance.
Use the Anuh Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Anuh Pharma Market Cap
₹791.87 Cr.
ANUHPHR P/E Ratio (TTM)
19.41
Anuh Pharma P/B Ratio
2.26
EPS (TTM)
₹4.10
Dividend Yield
1.88%
Debt to Equity
0.02
ANUHPHR 52 Week High
₹99.41
Anuh Pharma 52 Week Low
₹67.00
Operating Margin
8.00%
Profit Margin
5.05%
ANUHPHR Revenue (TTM)
₹772.00
EBITDA
₹62.00
Net Income
₹39.00
Total Assets
₹557.00
Total Equity
₹352.00
Anuh Pharma Share Price Chart
Screen Anuh Pharma share price with an interactive chart. Analyse ANUHPHR price trends and volatility across different timeframes.
Anuh Pharma Company Profile - Fundamental Screener
Screen Anuh Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ANUHPHR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE489G01022
Anuh Pharma Balance Sheet Screener
Screen ANUHPHR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 557 | 507 | 446 | 405 | 347 | 333 | 326 | 240 | 209 | 189 |
| Current Assets | 451 | 376 | 339 | 308 | 259 | 238 | 223 | 152 | 154 | 138 |
| Fixed Assets | 57 | 58 | 49 | 53 | 61 | 71 | 84 | 21 | 17 | 17 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 352 | 326 | 291 | 241 | 214 | 191 | 162 | 165 | 150 | 141 |
| Share Capital | 50 | 25 | 25 | 25 | 25 | 25 | 13 | 13 | 13 | 13 |
| Reserves & Surplus | 302 | 301 | 266 | 216 | 189 | 166 | 150 | 152 | 137 | 128 |
Anuh Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Anuh Pharma income statement and profit fundamentals.
Analyze ANUHPHR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Anuh Pharma share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 772 | 671 | 659 | 534 | 492 | 443 | 311 | 325 | 246 | 214 | 330 | 289 |
| Expenses | 710 | 601 | 572 | 476 | 440 | 387 | 284 | 291 | 220 | 184 | 290 | 254 |
| EBITDA | 62 | 70 | 87 | 57 | 52 | 55 | 27 | 34 | 25 | 30 | 40 | 35 |
| Operating Profit % | 8.00% | 9.00% | 12.00% | 10.00% | 10.00% | 10.00% | 7.00% | 9.00% | 8.00% | 11.00% | 11.00% | 11.00% |
| Depreciation | 11 | 9 | 9 | 10 | 12 | 15 | 7 | 2 | 2 | 2 | 2 | 3 |
| Interest | 0 | 1 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 54 | 61 | 78 | 48 | 39 | 39 | 19 | 32 | 23 | 28 | 38 | 32 |
| Tax | 15 | 14 | 18 | 11 | 9 | 10 | 5 | 9 | 7 | 8 | 12 | 10 |
| Net Profit | 39 | 47 | 60 | 36 | 31 | 28 | 14 | 23 | 17 | 20 | 26 | 22 |
| EPS | 4.10 | 9.45 | 11.98 | 7.22 | 6.10 | 5.67 | 2.85 | 9.33 | 6.59 | 8.00 | 10.30 | 8.78 |
Anuh Pharma Cash Flow Screener - Liquidity Fundamentals
Screen ANUHPHR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 37 | 13 | 54 | 29 | -19 | 49 | 7 | 2 | 26 | 17 |
| Investing Activities | -20 | 1 | -44 | -8 | 52 | -77 | 3 | 2 | -20 | -5 |
| Financing Activities | -5 | -9 | -12 | -20 | -33 | 22 | -7 | -5 | -4 | -9 |
| Net Cash Flow | 12 | 5 | -2 | 2 | 0 | -5 | 4 | -1 | 2 | 2 |
Anuh Pharma Shareholding Pattern Screener
See Anuh Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Anuh Pharma promoter holding and ownership changes for ANUHPHR on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Jul | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.80% | 69.92% | 69.92% | 69.92% | 71.82% | 71.82% | 69.92% | 69.92% |
| FII Holding | 0.05% | 0.04% | 0.04% | 0.03% | 0.00% | 0.00% | 0.03% | 0.03% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.11% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.57% | 25.92% | 25.89% | 25.83% | 23.86% | 23.74% | 26.20% | 26.30% |
| Other Holding | 4.59% | 4.13% | 4.16% | 4.23% | 4.33% | 4.44% | 3.75% | 3.75% |
| Shareholder Count | 27,425 | 24,235 | 24,257 | 26,157 | 28,250 | 27,889 | 22,237 | 23,494 |
Anuh Pharma Share Dividend Screener - Share Yield Analysis
Check Anuh Pharma dividend history with payout and yield data.
View Anuh Pharma dividend details including ex-dates and amounts for ANUHPHR stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.50 | 2.24% |
| 2024-March | ₹2.50 | 3.35% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Anuh Pharma Stock Index Membership
See which indices include Anuh Pharma stock.
Check ANUHPHR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Anuh Pharma Market Events Screener - Corporate Actions
Get Anuh Pharma corporate actions including splits, bonuses, and buybacks.
Check Anuh Pharma stock events that may affect ANUHPHR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-12 | 2026-08-12 | Annual General Meeting | NA | -0.98% |
| 2026-08-05 | 2026-08-05 | Dividend | ₹ 1.50 /share | -0.98% |
| 2026-05-20 | 2026-05-20 | Quarterly Result Announcement | NA | 0.78% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 7.85% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -3.79% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | -13.23% |
| 2025-08-14 | 2025-08-15 | Dividend | ₹ 1.50 /share | -16.76% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -7.61% |
| 2025-07-15 | 2025-07-15 | Bonus | 1:1 | -5.91% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 17.41% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | 5.24% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 5.11% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | -12.70% |
| 2024-08-16 | 2024-08-16 | Dividend | ₹ 2.50 /share | -13.94% |
| 2023-08-11 | 2023-08-11 | Dividend | ₹ 2.00 /share | 40.69% |
Anuh Pharma Competitors Screener - Peer Comparison
Screen ANUHPHR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 463,695 | 40.65 | 61,674 | 12.69% | 11,565 | 62.67 |
| Divis Laboratories | 192,398 | 75.67 | 10,560 | 8.73% | 2,520 | 69.61 |
| Torrent Pharmaceuticals | 181,169 | 79.18 | 13,886 | 20.34% | 2,138 | 53.08 |
| Zydus Life Science | 115,083 | 22.46 | 27,658 | 17.64% | 5,026 | 59.19 |
| Cipla | 114,609 | 29.90 | 29,045 | 2.24% | 3,870 | 48.42 |
| Lupin | 111,711 | 21.34 | 29,039 | 26.75% | 5,356 | 54.70 |
| Mankind Pharma | 102,596 | 54.23 | 14,636 | 14.85% | 1,938 | 50.34 |
| Dr Reddys Laboratories | 101,095 | 24.57 | 35,059 | 3.90% | 4,158 | 31.90 |
| Aurobindo Pharma | 88,228 | 25.67 | 33,385 | 3.21% | 3,376 | 50.49 |
| Laurus Labs | 82,587 | 94.51 | 6,868 | 22.01% | 890 | 59.60 |
Anuh Pharma Company Announcements - News Screener
Screen ANUHPHR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-23 | General Updates | - |
| 2026-07-23 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-23 | Reg. 34 (1) Annual Report. | - |
| 2026-07-23 | Shareholder Meeting - Annual General Meeting On Wednesday 12Th August 2026 | - |
| 2026-07-19 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-20 | Clarification For Newspaper Publication | - |
| 2026-06-19 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR) | - |
| 2026-06-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-29 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-25 | Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-22 | Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-20 | Announcement Under Regulation 30 (LODR) - Adoption For Policy For Implementation Of NFRA Circular | - |
| 2026-05-20 | Announcement Under Regulation 30 (LODR) - Appointment Of Scrutinizer For The 66Th Annual General Meeting. | - |
| 2026-05-20 | Announcement Under Regulation 30 (LODR) - 66Th Annual General Meeting Will Be Held On Wednesday 12Th August 2026. | - |
| 2026-05-20 | Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-20 | Announcement Under Regulation 30 (LODR) - Granting Authorization To Key Managerial Personnel For Determination Of Materiality Of Events. | - |
| 2026-05-20 | Announcement Under Regulation 30 (LODR) - Adoption Of Memorandum Of Association (MOA) And Articles Of Association (AOA) As Per Companies Act 2013 | - |